Acting FDA chief seeks pro-life reassurance after Planned Parenthood ties emerge
TL;DR Summary
Acting FDA Commissioner Kyle Diamantas has been telling anti‑abortion leaders he personally opposes abortion while facing questions about past work as outside counsel for a Planned Parenthood Florida clinic (2014–2017) and his later removal from that case for conscience reasons; some filings still list him, prompting skepticism from conservatives. The FDA has pledged a science‑based review of the abortion pill’s REMS and to provide updates, while Diamantas did not respond to questions about the case; the White House defended him amid ongoing debates over mifepristone policy and the agency’s leadership.
- Acting FDA leader tries to explain past Planned Parenthood work to abortion opponents Politico
- Top Drug Regulator Is Fired From the F.D.A. The New York Times
- FDA shuffles top drug, biologics leaders in latest shakeup CNBC
- FDA Revamp Begins With the Departure of a Marty Makary Ally Bloomberg.com
- Opinion | A desperately needed reset at the FDA The Washington Post
Reading Insights
Total Reads
0
Unique Readers
3
Time Saved
10 min
vs 11 min read
Condensed
96%
2,061 → 90 words
Want the full story? Read the original article
Read on Politico